Peptineo provides Nano-based therapeutics for existing and emerging diseases.
Peptineo represents the new face of biotechnology and bioengineering. The systems-based approach, Peptineo technical solutions involve drug delivery combinations including “tunable” nano-carriers, engineered peptides, re-formulated pharmaceuticals, and as appropriate, recombinant proteins. Additionally, Peptineo is developing technologies that will greatly enhance and accelerate the drug discovery process.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 5, 2014 | Seed | — | 1 | — | — | Detail |